Therapeutics: Glucose-dependent insulinotropic polypeptide (GIP) receptor; glucagon-like peptide-1 receptor (GLP-1R; GLP1R); glucagon receptor (GCGR)

Endocrine/metabolic disease

INDICATION: Obesity; diabetes

Mouse studies suggest a monomeric peptide agonist of GIP receptor,

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE